{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T14:40:05Z","timestamp":1749480005770,"version":"3.41.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010274","name":"Daegu Gyeongbuk Institute of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003562","name":"Ministry of Environment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003562","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2023-00230402"],"award-info":[{"award-number":["RS-2023-00230402"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003654","name":"Korea Environmental Industry and Technology Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003654","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003081","name":"Ministry of Education, Ethiopia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011512","name":"National Science Foundation, United Arab Emirates","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011512","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["-2023-NR76747"],"award-info":[{"award-number":["-2023-NR76747"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biophysical Chemistry"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bpc.2025.107470","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T23:39:25Z","timestamp":1747697965000},"page":"107470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Identification of potential Abl kinase inhibitors using virtual screening and free energy calculations for the treatment of chronic myeloid leukemia"],"prefix":"10.1016","volume":"324","author":[{"given":"Beom Soo","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wookyung","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpc.2025.107470_bb0005","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1038\/sj.onc.1203878","article-title":"Regulation of cell death by the Abl tyrosine kinase","volume":"19","author":"Wang","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.bpc.2025.107470_bb0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0065-230X(02)85003-5","article-title":"The Abl family kinases: mechanisms of regulation and signaling","volume":"85","author":"Pendergast","year":"2002","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.bpc.2025.107470_bb0015","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.cub.2004.07.021","article-title":"Requirement for Abl kinases in T cell receptor signaling","volume":"14","author":"Zipfel","year":"2004","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bpc.2025.107470_bb0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.V45.3.321.321","article-title":"Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome","volume":"45","author":"Lozzio","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.bpc.2025.107470_bb0025","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","article-title":"Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome","volume":"344","author":"Druker","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bpc.2025.107470_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14010215","article-title":"BCR-ABL1 tyrosine kinase complex signaling transduction: challenges to overcome resistance in chronic myeloid leukemia","volume":"14","author":"Amarante-Mendes","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bpc.2025.107470_bb0035","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1158\/0008-5472.CAN-12-1276","article-title":"The growing arsenal of ATP-competitive and allosteric inhibitors of BCR-ABL","volume":"72","author":"Hantschel","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.bpc.2025.107470_bb0040","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/PPO.0b013e31823dec8d","article-title":"Evolution of therapies for chronic myelogenous leukemia","volume":"17","author":"Santos","year":"2011","journal-title":"Cancer J."},{"key":"10.1016\/j.bpc.2025.107470_bb0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1172\/JCI9083","article-title":"Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia","volume":"105","author":"Druker","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bpc.2025.107470_bb0050","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.bpc.2025.107470_bb0055","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","article-title":"The development of imatinib as a therapeutic agent for chronic myeloid leukemia","volume":"105","author":"Deininger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bpc.2025.107470_bb0060","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/PPO.0b013e318237e5b7","article-title":"Development of an effective therapy for chronic myelogenous leukemia","volume":"17","author":"Woessner","year":"2011","journal-title":"Cancer J."},{"key":"10.1016\/j.bpc.2025.107470_bb0065","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.leukres.2010.04.016","article-title":"BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: a review","volume":"34","author":"An","year":"2010","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bpc.2025.107470_bb0070","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S1470-2045(07)70342-X","article-title":"Part I: mechanisms of resistance to imatinib in chronic myeloid leukaemia","volume":"8","author":"Apperley","year":"2007","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bpc.2025.107470_bb0075","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bpc.2025.107470_bb0080","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/nsmb.1486","article-title":"Activation of tyrosine kinases by mutation of the gatekeeper threonine","volume":"15","author":"Azam","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bpc.2025.107470_bb0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ccr.2005.01.007","article-title":"Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl","volume":"7","author":"Weisberg","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bpc.2025.107470_bb0090","doi-asserted-by":"crossref","first-page":"6977","DOI":"10.1016\/j.bmc.2010.08.026","article-title":"Structural resemblances and comparisons of the relative pharmacological properties of imatinib and nilotinib","volume":"18","author":"Manley","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bpc.2025.107470_bb0095","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1021\/jm049486a","article-title":"Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src\/Abl kinase inhibitor with potent antitumor activity in preclinical assays","volume":"47","author":"Lombardo","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bpc.2025.107470_bb0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bbapap.2005.07.040","article-title":"Advances in the structural biology, design and clinical development of Bcr-Abl kinase inhibitors for the treatment of chronic myeloid leukaemia","volume":"1754","author":"Manley","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bpc.2025.107470_bb0105","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1182\/blood-2004-05-1851","article-title":"Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML","volume":"104","author":"O'Hare","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bpc.2025.107470_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2021.100796","article-title":"Anticancer drug resistance: An update and perspective","volume":"59","author":"Nussinov","year":"2021","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bpc.2025.107470_bb0115","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1038\/leu.2014.153","article-title":"Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib","volume":"28","author":"Hanfstein","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.bpc.2025.107470_bb0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11899-016-0309-2","article-title":"Long-term side effects of tyrosine kinase inhibitors in chronic myeloid leukemia","volume":"11","author":"Caldemeyer","year":"2016","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"10.1016\/j.bpc.2025.107470_bb0125","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/leu.2010.215","article-title":"Management of adverse events associated with tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia","volume":"25","author":"Jabbour","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.bpc.2025.107470_bb0130","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.hoc.2017.04.007","article-title":"Mechanisms of resistance to ABL kinase inhibition in chronic myeloid leukemia and the development of next generation ABL kinase inhibitors","volume":"31","author":"Patel","year":"2017","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.bpc.2025.107470_bb0135","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/s41573-021-00252-y","article-title":"Trends in kinase drug discovery: targets, indications and inhibitor design","volume":"20","author":"Attwood","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bpc.2025.107470_bb0140","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41573-021-00195-4","article-title":"Kinase drug discovery 20 years after imatinib: progress and future directions","volume":"20","author":"Cohen","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bpc.2025.107470_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415961","article-title":"A comprehensive survey of prospective structure-based virtual screening for early drug discovery in the past fifteen years","volume":"23","author":"Zhu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bpc.2025.107470_bb0150","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1021\/ci200528d","article-title":"Recognizing pitfalls in virtual screening: a critical review","volume":"52","author":"Scior","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bpc.2025.107470_bb0155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-1-4939-6634-9_5","article-title":"Computer-aided drug design methods","volume":"1520","author":"Yu","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bpc.2025.107470_bb0160","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fchem.2020.00343","article-title":"Structure-based virtual screening: from classical to artificial intelligence","volume":"8","author":"Maia","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.bpc.2025.107470_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/wcms.1544","article-title":"Structure based virtual screening: fast and slow","volume":"12","author":"Varela-Rial","year":"2022","journal-title":"WIREs Comput. Mol. Sci."},{"key":"10.1016\/j.bpc.2025.107470_bb0170","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1038\/d41586-019-03846-0","article-title":"Hunting for new drugs with AI","volume":"576","author":"Freedman","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bpc.2025.107470_bb0175","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1021\/ci3001277","article-title":"ZINC: a free tool to discover chemistry for biology","volume":"52","author":"Irwin","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bpc.2025.107470_bb0180","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","article-title":"ZINC 15--Ligand Discovery for Everyone","volume":"55","author":"Sterling","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bpc.2025.107470_bb0185","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1021\/acs.jcim.0c00675","article-title":"ZINC20-a free Ultralarge-scale chemical database for ligand discovery","volume":"60","author":"Irwin","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bpc.2025.107470_bb0190","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bpc.2025.107470_bb0195","doi-asserted-by":"crossref","first-page":"W422","DOI":"10.1093\/nar\/gkae236","article-title":"ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support","volume":"52","author":"Fu","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bpc.2025.107470_bb0200","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13045-018-0624-2","article-title":"Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy","volume":"11","author":"Rossari","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bpc.2025.107470_bb0205","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1021\/acs.jcim.5b00654","article-title":"Better informed distance geometry: using what we know to improve conformation generation","volume":"55","author":"Riniker","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bpc.2025.107470_bb0210","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1021\/acs.jcim.0c00025","article-title":"Improving conformer generation for small rings and macrocycles based on distance geometry and experimental torsional-angle preferences","volume":"60","author":"Wang","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bpc.2025.107470_bb0215","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/jcc.20681","article-title":"Ultrafast shape recognition to search compound databases for similar molecular shapes","volume":"28","author":"Ballester","year":"2007","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bpc.2025.107470_bb0220","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jmgm.2009.01.001","article-title":"Ultrafast shape recognition: evaluating a new ligand-based virtual screening technology","volume":"27","author":"Ballester","year":"2009","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.bpc.2025.107470_bb0225","article-title":"USRCAT: real-time ultrafast shape recognition with pharmacophoric constraints","volume":"4","author":"Schreyer","year":"2012","journal-title":"J. Chem."},{"key":"10.1016\/j.bpc.2025.107470_bb0230","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1021\/acs.jcim.1c01535","article-title":"On the value of using 3D shape and electrostatic similarities in deep generative methods","volume":"62","author":"Bolcato","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bpc.2025.107470_bb0235","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ccr.2011.03.003","article-title":"Conformational control inhibition of the BCR-ABL1 tyrosine kinase, including the gatekeeper T315I mutant, by the switch-control inhibitor DCC-2036","volume":"19","author":"Chan","year":"2011","journal-title":"Cancer Cell"},{"year":"2024","series-title":"Amber 2024","author":"Case","key":"10.1016\/j.bpc.2025.107470_bb0240"},{"key":"10.1016\/j.bpc.2025.107470_bb0245","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1021\/acs.jcim.3c01153","article-title":"The AmberTools","volume":"63","author":"Case","year":"2023","journal-title":"J. Chem. Inform. Model."},{"key":"10.1016\/j.bpc.2025.107470_bb0250","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","article-title":"ff19SB: amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution","volume":"16","author":"Tian","year":"2020","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bpc.2025.107470_bb0255","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Software news and update AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bpc.2025.107470_bb0260","doi-asserted-by":"crossref","first-page":"W530","DOI":"10.1093\/nar\/gkab294","article-title":"PLIP 2021: Expanding the scope of the protein-ligand interaction profiler to DNA and RNA","volume":"49","author":"Adasme","year":"2021","journal-title":"Nucleic Acids Res."},{"year":"2015","series-title":"The PyMOL Molecular Graphics System","author":"Schrodinger","key":"10.1016\/j.bpc.2025.107470_bb0265"},{"key":"10.1016\/j.bpc.2025.107470_bb0270","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.bpc.2025.107470_bb0275","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","article-title":"Automatic atom type and bond type perception in molecular mechanical calculations","volume":"25","author":"Wang","year":"2006","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.bpc.2025.107470_bb0280","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bpc.2025.107470_bb0285","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/jcc.10128","article-title":"Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation","volume":"23","author":"Jakalian","year":"2002","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bpc.2025.107470_bb0290","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.Py: An efficient program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theory Comput."},{"year":"2016","series-title":"Gaussian 09, Revision A.02","author":"Frisch","key":"10.1016\/j.bpc.2025.107470_bb0295"},{"key":"10.1016\/j.bpc.2025.107470_bb0300","doi-asserted-by":"crossref","first-page":"9620","DOI":"10.1021\/ja00074a030","article-title":"Application of Resp charges to calculate conformational energies, hydrogen-bond energies, and free-energies of solvation","volume":"115","author":"Cornell","year":"1993","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bpc.2025.107470_bb0305","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0009-2614(94)00397-1","article-title":"Avoiding singularities and numerical instabilities in free-energy calculations based on molecular simulations","volume":"222","author":"Beutler","year":"1994","journal-title":"Chem. Phys. Lett."},{"key":"10.1016\/j.bpc.2025.107470_bb0310","doi-asserted-by":"crossref","first-page":"9535","DOI":"10.1021\/jp0217839","article-title":"Absolute binding free energies: a quantitative approach for their calculation","volume":"107","author":"Boresch","year":"2003","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bpc.2025.107470_bb0315","doi-asserted-by":"crossref","DOI":"10.1063\/1.2978177","article-title":"Statistically optimal analysis of samples from multiple equilibrium states","volume":"129","author":"Shirts","year":"2008","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.bpc.2025.107470_bb0320","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.21105\/joss.06934","article-title":"Alchemlyb: the simple alchemistry library","volume":"9","author":"Wu","year":"2024","journal-title":"J. Open Source Softw."},{"key":"10.1016\/j.bpc.2025.107470_bb0325","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bpc.2025.107470_bb0330","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1016\/j.bmcl.2008.07.071","article-title":"Physiochemical drug properties associated with in vivo toxicological outcomes","volume":"18","author":"Hughes","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bpc.2025.107470_bb0335","doi-asserted-by":"crossref","first-page":"5560","DOI":"10.1016\/j.bmcl.2009.08.045","article-title":"Using the Golden triangle to optimize clearance and oral absorption","volume":"19","author":"Johnson","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bpc.2025.107470_bb0340","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1107\/S0907444906047287","article-title":"Structural biology contributions to the discovery of drugs to treat chronic myelogenous leukaemia","volume":"63","author":"Cowan-Jacob","year":"2007","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"Suppl. 5","key":"10.1016\/j.bpc.2025.107470_bb0345","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S0959-8049(02)80599-8","article-title":"Imatinib: a selective tyrosine kinase inhibitor","volume":"38","author":"Manley","year":"2002","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bpc.2025.107470_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094435","article-title":"Deep learning in virtual screening: recent applications and developments","volume":"22","author":"Kimber","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bpc.2025.107470_bb0355","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1021\/acs.jcim.9b00387","article-title":"Predicting drug-target interaction using a novel graph neural network with 3D structure-embedded graph representation","volume":"59","author":"Lim","year":"2019","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bpc.2025.107470_bb0360","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1021\/acs.jcim.7b00403","article-title":"Most ligand-based classification benchmarks reward memorization rather than generalization","volume":"58","author":"Wallach","year":"2018","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bpc.2025.107470_bb0365","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1021\/acs.jcim.0c01344","article-title":"Coloring molecules with explainable artificial intelligence for preclinical relevance assessment","volume":"61","author":"Jimenez-Luna","year":"2021","journal-title":"J. Chem. Inf. Model."},{"year":"2016","series-title":"Deep Learning","author":"Goodfellow","key":"10.1016\/j.bpc.2025.107470_bb0370"}],"container-title":["Biophysical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301462225000821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301462225000821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T14:07:10Z","timestamp":1749478030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301462225000821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":74,"alternative-id":["S0301462225000821"],"URL":"https:\/\/doi.org\/10.1016\/j.bpc.2025.107470","relation":{},"ISSN":["0301-4622"],"issn-type":[{"type":"print","value":"0301-4622"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of potential Abl kinase inhibitors using virtual screening and free energy calculations for the treatment of chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Biophysical Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpc.2025.107470","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107470"}}